Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ED 110

Known as: ED-110 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
All four "symmetrical" regioisomers of ED-110, an indolocarbazole derivative having potent activity against human topoisomerase I… Expand
Is this relevant?
1997
1997
DNA topoisomerase I has been shown to be an important therapeutic target in cancer chemotherapy for the camptothecins as well as… Expand
Is this relevant?
1993
1993
ED-110 is a new semisynthetic antitumor agent derived from a novel indolocarbazole antibiotic, BE-13793C, produced by an… Expand
Is this relevant?
1993
1993
A new indolocarbazole compound, ED-110, which was obtained by glucosylating a microbial product (BE-13793C) and is a potent… Expand
Is this relevant?
1992
1992
^TV-dimethylformamide (DMF, 37 ml) was added potassium carbonate (510mg, 3.69mmol) and benzyl bromide (170^1, 1.43mmol) at room… Expand
  • figure 1
Is this relevant?